These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24811250)

  • 21. [Anti-tumor mechanism of norcantharidin for the implanted tumors of human gallbladder carcinoma in nude mice in vivo].
    Fan YZ; Zhao ZM; Fu JY; Chen CQ
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):618-22. PubMed ID: 16784656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
    Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
    Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling.
    Zang M; Zhang Y; Zhang B; Hu L; Li J; Fan Z; Wang H; Su L; Zhu Z; Li C; Yan C; Gu Q; Liu B; Yan M
    Biochim Biophys Acta; 2015 May; 1852(5):1020-8. PubMed ID: 25703140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells.
    Mei L; Sang W; Cui K; Zhang Y; Chen F; Li X
    Cancer Sci; 2019 Feb; 110(2):582-595. PubMed ID: 30520540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR‑141 inhibits glioma vasculogenic mimicry by controlling EphA2 expression.
    Li G; Huang M; Cai Y; Ke Y; Yang Y; Sun X
    Mol Med Rep; 2018 Aug; 18(2):1395-1404. PubMed ID: 29901110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Norcantharidin enhances bortezomib-antimyeloma activity in multiple myeloma cells in vitro and in nude mouse xenografts.
    Du HF; Yu LJ; Meng YF; Lv HY; Meng J; Song XN; Zhang JQ
    Leuk Lymphoma; 2013 Mar; 54(3):607-18. PubMed ID: 22889356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways.
    Zhang L; Ji Q; Liu X; Chen X; Chen Z; Qiu Y; Sun J; Cai J; Zhu H; Li Q
    Cancer Sci; 2013 May; 104(5):604-10. PubMed ID: 23363445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing.
    Li M; Chen L; Qu Y; Sui F; Yang Q; Ji M; Shi B; Chen M; Hou P
    Oncotarget; 2017 May; 8(22):36319-36330. PubMed ID: 28422736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genistein inhibits the growth and regulates the migration and invasion abilities of melanoma cells via the FAK/paxillin and MAPK pathways.
    Cui S; Wang J; Wu Q; Qian J; Yang C; Bo P
    Oncotarget; 2017 Mar; 8(13):21674-21691. PubMed ID: 28423510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focal adhesion kinase signaling and the aggressive melanoma phenotype.
    Hess AR; Hendrix MJ
    Cell Cycle; 2006 Mar; 5(5):478-80. PubMed ID: 16552181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of p38 MAPK Pathway to Norcantharidin-Induced Programmed Cell Death in Human Oral Squamous Cell Carcinoma.
    Ahn CH; Hong KO; Jin B; Lee W; Jung YC; Lee H; Shin JA; Cho SD; Hong SD
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oridonin inhibits hypoxia-induced epithelial-mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer.
    Chen K; Ye J; Qi L; Liao Y; Li R; Song S; Zhou C; Feng R; Zhai W
    Anticancer Drugs; 2019 Oct; 30(9):925-932. PubMed ID: 31517732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oroxylin A Exerts Its Antitumor Effects in Human Gallbladder Cancer via Inhibition of the PTEN/PI3K/AKT Signaling Pathway.
    Xuan L; Zhang J; Ji J; Hu J; Li F
    Biol Pharm Bull; 2020; 43(10):1511-1518. PubMed ID: 32999161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway.
    Shen Y; Bian R; Li Y; Gao Y; Liu Y; Xu Y; Song X; Zhang Y
    Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):607-614. PubMed ID: 31074773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.
    Lu W; Hu Y; Ma Q; Zhou L; Jiang L; Li Z; Zhao S; Xu Y; Shi W; Li S; Liu Y
    Oncotarget; 2016 Sep; 7(38):62364-62376. PubMed ID: 27577078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norcantharidin induces melanoma cell apoptosis through activation of TR3 dependent pathway.
    Liu S; Yu H; Kumar SM; Martin JS; Bing Z; Sheng W; Bosenberg M; Xu X
    Cancer Biol Ther; 2011 Dec; 12(11):1005-14. PubMed ID: 22123174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RhoC/ROCK2 promotes vasculogenic mimicry formation primarily through ERK/MMPs in hepatocellular carcinoma.
    Zhang JG; Zhang DD; Liu Y; Hu JN; Zhang X; Li L; Mu W; Zhu GH; Li Q; Liu GL
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1113-1125. PubMed ID: 30779947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
    Johnson FM; Saigal B; Talpaz M; Donato NJ
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
    Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
    World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.